Synthesis of Tetracyclines and intermediates thereto

US9688644B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9688644-B2
Application numberUS-201514792493-A
CountryUS
Kind codeB2
Filing dateJul 6, 2015
Priority dateApr 30, 2009
Publication dateJun 27, 2017
Grant dateJun 27, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The tetracycline class of antibiotics has played a major role in the treatment of infectious diseases for the past 50 years. However, the increased use of the tetracyclines in human and veterinary medicine has led to resistance among many organisms previously susceptible to tetracycline antibiotics. The recent development of a modular synthesis of tetracycline analogs through a chiral enone intermediate has allowed for the efficient synthesis of novel tetracycline analogs never prepared before. The present invention provides more efficient routes for preparing the enone intermediate and allows for substituents at positions 4a, 5, 5a, and 12a of the tetracycline ring system.

First claim

Opening claim text (preview).

What is claimed is: 1. A compound of formula (VII): or a salt thereof; wherein: R 3 and R 4 are each independently hydrogen; halogen; cyclic or acyclic, substituted or unsubstituted, branched or unbranched aliphatic; cyclic or acyclic, substituted or unsubstituted, branched or unbranched heteroaliphatic; substituted or unsubstituted, branched or unbranched acyl; substituted or unsubstituted aryl; substituted or unsubstituted heteroaryl; —OR B ; —CH 2 OR B ; —CH 2 R B ; —CH 2 N(R B ) 2 ; —C(═O)R B ; —CO 2 R B ; —CN; —SCN; —SR B ; —SOR B ; —SO 2 R B ; —N 3 ; —NO 2 ; —N(R B ) 2 ; —NHC(O)R B ; —NHSO 2 R B ; or —C(R B ) 3 ; wherein each occurrence of R B is independently hydrogen, halogen, azido, a protecting group, aliphatic, heteroaliphatic, haloaliphatic, acyl, aryl, heteroaryl, alkoxy, aryloxy, alkylthio, arylthio, amino, alkylamino, dialkylamino, heteroaryloxy, or heteroarylthio; or R 3 and R 4 are taken together to form ═O or ═C(R B ) 2 ; R 5 , R 9 , R 10 , and R 11 are each independently hydrogen; halogen; cyclic or acyclic, substituted or unsubstituted, branched or unbranched aliphatic; cyclic or acyclic, substituted or unsubstituted, branched or unbranched heteroaliphatic; substituted or unsubstituted, branched or unbranched acyl; substituted or unsubstituted aryl; substituted or unsubstituted heteroaryl; —OR C ; —CH 2 OR C ; —CH 2 R C ; —CH 2 N(R C ) 2 ; —C(═O)R C ; —CO 2 R C ; —CN; —SCN; —SR C ; —SOR C ; —SO 2 R C ; —N 3 ; —NO 2 ; —N(R C ) 2 ; —NHC(O)R C ; —NHSO 2 R C ; or —C(R C ) 3 ; wherein each occurrence of R C is independently hydrogen, halogen, azido, a protecting group, aliphatic, heteroaliphatic, haloaliphatic, acyl, aryl, heteroaryl, alkoxy, aryloxy, alkylthio, arylthio, amino, alkylamino, dialkylamino, heteroaryloxy, or heteroarylthio; or R 5 is ═C(R C ) 2 ; and R P is hydrogen, substituted or unsubstituted aliphatic, substituted or unsubstituted heteroaliphatic, haloaliphatic, a protecting group, substituted or unsubstituted acyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; provided that when R 9 is —OR C , then R 10 and R 11 are not simultaneously hydrogen. 2. The compound of claim 1 , wherein R 3 is hydrogen, halogen, —OR B , or C 1-6 alkyl. 3. The compound of claim 1 , wherein R 4 is hydrogen, halogen, —OR B , or C 1-6 alkyl. 4. The compound of claim 1 , wherein R 5 is —N(R C ) 2 or —OR C . 5. The compound of claim 1 , wherein R 9 is —OR C . 6. The compound of claim 1 , wherein R 9 is C 1-6 alkyl. 7. The compound of claim 1 , wherein R 9 is —N(R C ) 2 . 8. The compound of claim 1 , wherein R 10 is substituted or unsubstituted alkyl, —OR C , or halogen. 9. The compound of claim 1 , wherein R 11 is hydrogen or substituted or unsubstituted alkyl. 10. The compound of claim 1 , wherein R 11 is —OR C or —N(R C ) 2 . 11. The compound of claim 1 of formula: or a salt thereof. 12. The compound of claim 1 of formula: or a salt thereof. 13. The compound of claim 1 of formula: or a salt thereof. 14. The compound of claim 1 , wherein R 10 is halogen; cyclic or acyclic, substituted or unsubstituted, branched or unbranched aliphatic; cyclic or acyclic, substituted or unsubstituted, branched or unbranched heteroaliphatic; substituted or unsubstituted, branched or unbranched acyl; substituted or unsubstituted aryl; substituted or unsubstituted heteroaryl; —OR C ; —CH 2 OR C ; —CH 2 R C ; —CH 2 N(R C ) 2 ; —C(═O)R C ; —CO 2 R C ; —CN; —SCN; —SR C ; —SOR C ; —SO 2 R C ; —N 3 ; —NO 2 ; —N(R C ) 2 ; —NHC(O)R C ; —NHSO 2 R C ; or —C(R C ) 3 . 15. A method of preparing an enone of formula (VII): or a salt thereof; wherein: R 3 and R 4 are each independently hydrogen; halogen; cyclic or acyclic, substituted or unsubstituted, branched or unbranched aliphatic; cyclic or acyclic, substituted or unsubstituted, branched or unbranched heteroaliphatic; substituted or unsubstituted, branched or unbranched acyl; substituted or unsubstituted aryl; substituted or unsubstituted heteroaryl; —OR B ; —CH 2 OR B ; —CH 2 R B ; —CH 2 N(R B ) 2 ; —C(═O)R B ; —CO 2 R B ; —CN; —SCN; —SR B ; —SOR B ; —SO 2 R B ; —N 3 ; —NO 2 ; —N(R B ) 2 ; —NHC(O)R B ; —NHSO 2 R B ; or —C(R B ) 3 ; wherein each occurrence of R B is independently hydrogen, halogen, azido, a protecting group, aliphatic, heteroaliphatic, haloaliphatic, acyl, aryl, heteroaryl, alkoxy, aryloxy, alkylthio, arylthio, amino, alkylamino, dialkylamino, heteroaryloxy, or heteroarylthio; or R 3 and R 4 are taken together to form ═O or ═C(R B ) 2 ; R 5 , R 9 , and R 11 are each independently hydrogen; halogen; cyclic or acyclic, substituted or unsubstituted, branched or unbranched aliphatic; cyclic or acyclic, substituted or unsubstituted, branched or unbranched heteroaliphatic; substituted or unsubstituted, branched or unbranched acyl; substituted or unsubstituted aryl; substituted or unsubstituted heteroaryl; —OR C ; —CH 2 OR C ; —CH 2 R C ; —CH 2 N(R C ) 2 ; —C(═O)R C ; —CO 2 R C ; —CN; —SCN; —SR C ; —SOR C ; —SO 2 R C ; —N 3 ; —NO 2 ; —N(R C ) 2 ; —NHC(O)R C ; —NHSO 2 R C ; or —C(R C ) 3 ; R 10 is hydrogencyclic or acyclic, substituted or unsubstituted, branched or unbranched aliphatic; cyclic or acyclic, substituted or unsubstituted, branched or unbranched heteroaliphatic; substituted or unsubstituted aryl; or substituted or unsubstituted heteroaryl; each occurrence of R C is independently hydrogen, halogen, azido, a protecting group, aliphatic, heteroaliphatic, haloaliphatic, acyl, aryl, heteroaryl, alkoxy, aryloxy, alkylthio, arylthio, amino, alkylamino, dialkylamino, heteroaryloxy, or heteroarylthio; each R P is independently hydrogen, substituted or unsubstituted aliphatic, substituted or unsubstituted heteroaliphatic, haloaliphatic, a protecting group, substituted or unsubstituted acyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; the method comprising steps of: (a) deprotonating an isoxazole of formula (I): or a salt thereof; with a base and reacting the deprotonated isoxazole with an enone of formula (II): or a salt thereof, wherein: each occurrence of R Q is independently hydrogen, C 1-6 alkyl, —Si(OR Z ) 3 , or —Si(R Z ) 3 , and each occurrence of R Z is independently hydrogen; halogen; cyclic or acyclic, substituted or unsubstituted, branched or unbranched aliphatic; cyclic or acyclic, substituted or unsubstituted, branched or unbranched heteroaliphatic; substituted or unsubstituted, branched or unbranched acyl; substituted or unsubstituted aryl; or a substituted or unsubstituted heteroaryl; to yield a compound of formula (III): or a salt thereof; wherein M is a counterion generated by the base; (b) treating the compound of formula (III) with a base

Assignees

Inventors

Classifications

  • the ring being saturated · CPC title

  • C07D261/20Primary

    condensed with carbocyclic rings or ring systems · CPC title

  • containing five-membered rings · CPC title

  • Antibacterial agents · CPC title

  • to acyclic carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9688644B2 cover?
The tetracycline class of antibiotics has played a major role in the treatment of infectious diseases for the past 50 years. However, the increased use of the tetracyclines in human and veterinary medicine has led to resistance among many organisms previously susceptible to tetracycline antibiotics. The recent development of a modular synthesis of tetracycline analogs through a chiral enone int…
Who is the assignee on this patent?
Harvard College
What technology area does this patent fall under?
Primary CPC classification C07D261/20. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 27 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).